Intervention Review

Galantamine for vascular cognitive impairment

  1. David Craig1,*,
  2. Jacqueline Birks2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 15 NOV 2005

DOI: 10.1002/14651858.CD004746.pub2

Database Title

Additional Information

How to Cite

Craig D, Birks J. Galantamine for vascular cognitive impairment. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004746. DOI: 10.1002/14651858.CD004746.pub2.

Author Information

  1. 1

    Queen's University Belfast, Department of Geriatric Medicine, Belfast, UK

  2. 2

    University of Oxford, Centre for Statistics in Medicine, Oxford, UK

*David Craig, Department of Geriatric Medicine, Queen's University Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast, BT9 7BL, UK. david.craig@qub.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (192K)Full (259K)

  1. Current Version

    Galantamine for vascular cognitive impairment

    David Craig and Jacqueline Birks

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD004746.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Galantamine for vascular cognitive impairment

    D Craig and J Birks

    Article first published online: 19 OCT 2005 | DOI: 10.1002/14651858.CD004746

View Full Article (HTML) Summary (58K)Standard (192K)Full (259K)